Showing results (131-140 of 189) with videos related to
Sort By:
Pageof 19
Plos One|August 21, 2008
Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II StudyMika Kivimäki, Debbie A Lawlor, George Davey Smith, et al.JACC. Cardiooncology|April 9, 2025
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal CancerAderonke T Abiodun, Chengsheng Ju, Catherine A Welch, et al.BMJ Oncology|January 31, 2025
Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignanciesAderonke Temilade Abiodun, Chengsheng Ju, Catherine A Welch, et al.Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.Cardiovascular Research|August 27, 2021
Standardized measurement of coronary inflammation using cardiovascular computed tomography: integration in clinical care as a prognostic medical deviceEvangelos K Oikonomou, Alexios S Antonopoulos, David Schottlander, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|July 16, 2013
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statementJosep Brugada, Nico Blom, Georgia Sarquella-Brugada, et al.Circulation. Cardiovascular Quality and Outcomes|June 20, 2023
Impact of a Prior Cancer Diagnosis on Quality of Care and Survival Following Acute Myocardial Infarction: Retrospective Population-Based Cohort Study in EnglandLucy Teece, Michael J Sweeting, Marlous Hall, et al.Diabetes Care|March 29, 2025
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized TrialsMatthew M Y Lee, Naveed Sattar, Rodica Pop-Busui, et al.Journal of Hypertension|January 22, 2005
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of HypertensionHanspeter Brunner, John R Cockcroft, John Deanfield, et al.Diabetes Care|February 21, 2016
Association Between Plasma Uric Acid Levels and Cardiorenal Function in Adolescents With Type 1 DiabetesYuliya Lytvyn, Farid H Mahmud, Denis Daneman, et al.Pageof 19